鸿博体育

2024-05-28

Haiwen Antitrust Group was invited to author an article for the Global Competition Review - "Asia-Pacific Antitrust Review 2024"

引言



近期,海问反专卖业务部门组受国际性全威法自媒体《全世界争夺评介》(Global Competition Review)的邀🦹請,为其“亚太国际反专卖评介2024”频道栏目下“Insight”教育板块刊文,对于中国国家在销售者低效审理业务领域公布的监察实现,简绍了僵化寄售申请程序流程ཧ图的治疗并上述展示了使用的指导与观点。

Recently, the authoritative internationalꦿ legal media Global Competition Review invited Haiwen Antitrust Group to author an Insight article for its Asia-Pacific Antitrust Review 2024. The ꦇarticle provides practical guidance and insights for handling merger control procedures of complex deals based on China’s most recent enforcement practice.

反垄断-1.jpg
Navigating Merger Review of Complex Deals under Chinese Anti-Monopoly Law in an Ever-Changing World
In summary
China’s Anti-Monopoly Law and the accompanying regulations concerning merger control have undergone significant changes in the past years. Amid the legislative changes and the ever-changing geopolitical conditions, the Chinese competition authority continues to hold a decisive influence on progressing complex cross-border deals with global impact. This article aims to provide practical guidance and insights for handling merger control procedures of complex deals based on China’s most recent enforcement practice. It highlights topics from planning optimal merger filing strategies to key considerations in remedy design and implementation.

Discussion points

· Identification of a complex deal

· Meger filing strategies for a complex deal

· Remedy design and negot💙iation when competition concerns are identified

· Implement✱ation of remedies in a cost-effective way

· Remedy lifting and modification


Introduction

The year 2023 witnesses the 15th anniversary of the enactment of China’s Anti-Monopoly Law (“AML”) and the first anniversary of its amendment. The State Administration for Market Regulation (“SAMR”), the Chinese competition regulatory authority, released the Provisions on the Review of Concentrations of Undertakings to adapt the accompanying regulations to the amended AML. At the beginning of 2024, SAMR revised the Rules of the State Council on the Declaration Standards for Concentration of Undertakings, wh🍌ich increased the turnover thresholds for merger controജl notifications.

Amid the above legislative improvements, China maintains its crucial presence in the global economy, continuing to attract international market players and giving rise to the fact that an enormous number of international M&A deals are required to put forward ex ante notifications before SAMR. The statistics published by SAMR show that 797 cases were accepted by SAMR in 2023 alone, 782 of which were approved un𝓡conditionally and 4 of which were approved with remedies. Deals involving foreign enterprises account for 44% of the cases approv❀ed.[1]

Most notably, SAMR’s decision plays a decisive role in progressing forward many high-profile deals with global influence in 2023, for instance, the MaxLinear/Silicon Motion (2023)[2] and Broadcom/VMware (2023). Although the turnover thresholds for merger notifications were e𒁏levated, which may lead to a decrease of approximately 200 cases annually, high-profile deals that are likely to restrict or eliminate competition or relate to certain industries with some special strategic con🌸siderations will still be under the spotlight of SAMR’s review. We term those deals as “complex deals” and will discuss in this article on how to navigate the merger review of them properly under the context of amended AML.

The article aims at providing practical guidanceℱ for handling complex deals over the lifetime of its review process under the AML, based on SAMR’s recent practice. We first reveal the characterist💞ics of complex deals and advise on the way of planning and designing appropriate and feasible merger filing strategies thereof. We then explore and highlight the key considerations in remedy design and implementation when the deal comes to the stage where relevant parties are required to propose and implement remedies.

The identification of a complex deal and the merger control filing strategy thereof

With the changing trade climate and the attendant upsurge in complicated geopolitics, it seems that the recent M&A deals tend to grind to a halt. Despite that, as one of the world’s important nexus for manufacturing and market activities, China is still a fertile ground for international deals of a high-profile nature.

Since the enactment of the AML in 2008, cases cleared with remedies by SAMR or its predecessor, the Anti-monopoly Bureau of the Ministry of Commerce (“MOFCOM”), have been a unique spotlight across worldwide major antitrust jurisdictions - as the world's largest manufacturing country, it is natural to look at issues from different perspectives, so that there will be differences in market definition, competitive analysis, etc. For those high-profile international deals, identifying the complexity of the deal appropriately and navigating the merger control filing strategy in advance have naturally become pivotal to progressing the deal.

The identification of a complex deal

In order to address the regulator’s ﷺconcerns to facilitate the merger review process, one has to appropriately identify whether the deal in question constitutes a “complex” one. Normally, there are two perspectives that are of consideration in this regard: competition assessment and industrial policy evaluation.

Competition assessment

Competition assessment is at the heart of a merger control review. Transactions that have or may have any effect of eliminating or restricting competition in China will certainly complicate the review process and lengthen the timelines. The regulator would take an in-depth review of the notifying parties’ submission of an assessment of the concentration’s competitive impact, evaluate any potential competition concerns 🌠and seek any possible commitments or remedies that can ease the concerns.

In order for the parties 🃏to identify a complex deal from a competition assessment perspective and be prepared in advance, one needs to learn what factors would be under SAMR’s radar. In line with international antitrust regulator’s practice, SAMR would adop♌t the theories of harm and assess the unilateral or coordinated effects for horizontal mergers and evaluate the foreclosure effects in case of vertical or conglomerate mergers. The following factors would be primarily considered in SAMR’s review process:

■  Market share, includ༒ing the parties’ m꧙arket position;

■  The degree of market concentration, which can be reflected via the Herfindahl-Hirschman Index (HHI) or▨ the combined market shares of the top N enterprises in the꧃ relevant market (CRn index);

■&nbs𓆏p; The impact of the concen🍎tration on market entry and technological advancement;

■  The impact of the concentration on consumers and other third parties 🌳(suppliers, competitors, counterparties, etc.);

■  The compe🏅tition landscape and the mar💫ket competitiveness pre and post the concentration; and

■  The impact of the concentra♚tion on economic efficiency, business scale and scope, and cost reduction.

It is worth mentioning that compared with other jurisdictions, SAMR tends to take a closer examination of those cases with high market shares despite the deal is a conglomerate transaction. Based on observations on SAMR’s recent practice, its conglomerate concerns primarily shadow on the possibl♋e tying, imposing less favourable trade terms post-transaction, refusal to deal, degrading interoperability, etc.

Industrial policy evaluation

In addition to weighing the competition-wide effects, other factors closely related to economic development, such as industrial policy, are also taken into account in the review process, which is in line with the legislative purpose of the AML set out in Article 1 thereof (safeguarding the interests of consumers and the public and promoting the sound development of the socialist market economy).[3] To be more specific, SAMR would consider the impact of the concentration on national economic development, i.e., SAMR would analyse the impact on economic efficiency, business scale, the development of the relevant industries, etc. In other words, SAMR would analyse industrial policy concerns during merger review process, in particular in deals involving industries that are of strategic importance to China and/or closely r𝔉elated to people’s livelihood, such as electronic information, semiconductor, aerospace, ocean engineering, new energy, new materials, agriculture, pharmaceuticals, etc. Thus, deals which fall within the above industries might need to be paid rigorous attention.

Taking deals in the field of agriculture as an example, despite moderate market shares in the relevant markets, if the deals are likely to have a significant and strategic impact on the agricultural value chain and thereby on people’s livelihood, they would be, in most cases, subject to strict and lengthy scrutiny and may be approved with restrictive cond🦄itions.

Given such, while a com꧙plex deal is at hand or around the corner, a close and early planned monitoring of the concerned industrial policies issued by the relevant governmental authority or trade association is a pragmatic and advis💖able approach.

The merger control filing strategy for a complex deal

As SAMR is increasingly playing an active role in reviewing complex deals, understanding China’s regulatory dynamics and practice, proactively planning and designing appropriate and feasible merger control filing strategy thereof, and adjusting such strategy from time to time based on actual reviewing process will help the de💮als gain an edge in getting clearance. While strategy-planning and designing may need to consider various perspectives, the following factors, among others, shall be weighed substantially.

Conduct holistic analysis towards the relevant markets and the competition landscape

Whereas a deal has been identified as a complex one, the traditional competition perspective assessment (as illustrated above) shall have already been properly conducted by the parties. However, a more holistic and in-depth analysis towards the relevant markets and the competition landscape might contribute more to addressing and alleviating SAMR’s potential concerns. Most of SAMR’s competition concerns stem from possible synergies the transaction parties might have and any input/customer foreclosure the transaction may result in. Thus, beyond the corresponding stances under the traditional competition perspective, it is advisable to take a closer assessment of the rate of capacity utilization, countervailing power from buyers, dynamic impact of new technology on the relevant industry, as well as any efficiency increment. Engaging economists and conducting detailed economic analysis might be of🤡 assistance as well.

Maintain an adequate and constructive communication with SAMR

For complex deals, adequate and constructive communications with SAMR tend to play a crucial part in smoothing the reviewing process. The communications can be of two parts: pre-filing and post-filing.

The parties can choose to take advantage of SAMR’s pre-filing consultation mechanism and apply for a preliminary communication with SAMR, during which the parties can seek SAMR’s guidance on procedural (such as review length, filing requirements, etc.) or substantive issues (such as market definition, market data caꦉlculation, industry policy, etc.) under the scheduled notification. The parties can then be more prepared and adjust/supplement the filing materials accordingly. Through this, SAMR’s inquiries on the completeness of the filing materials may be reduced to a certain extent and therefore might shorten SAMR’s pre-acceptance period.

Procedurally, upon SAMR’s formal acceptance of the case, SAMR will seek third-party stakeholders’ opinions on the transaction, which is a formal process under the non-simplified filing procedure. Usually, stakeholders would include PRC customers, suppliers, trade associations, sector regulators, etc., and their views and concerns would play an essential role when SAMR formulates its attitudes and competition concerns over the case. Thus, it is advisable to keep a smooth communication with SAMR post-acceptance, especially to anticipate proactive communic🍸ations after SAMR receives stakeholders’ opinions to get a sense on whether received opinions are negative/positive/𓄧neutral.

If 💃SAMR preliminarily identifies competiti꧟ve concerns over the case and intends to require remedies, it will normally call for a meeting to convey such concerns to the parties. The parties would then be required to formulate a commitment proposal to SAMR to address those concerns and to explain why such commitments could be able to lift those concerns effectively, which will lead to rounds of back-and-forth negotiations and discussions between parties and SAMR on possible remedies. For cases also being filed in other jurisdictions, SAMR would commonly exchange review opinions with its peer regulators, thus, parties need to coordinate remedy proposals across different jurisdictions as well, and maintain continuous and effective communications with both SAMR and its peer regulators.

Initiate appropriate and pragmatic stakeholders reachouts

As being mentioned above, stakeholders’ views and concerns over the transaction could be pivotal to SAMR’s stance on the necessity to impose remedies. In order to take initiatives over the reviewing process (including possible remedy negotiation process) and formulate a commitment proposal (if needed) as 𒆙soon as possible that can effectively address SAMR’s concerns and pass SAMR’s market test(s), the parties need to take the stakeholders reachouts seriously and commence the process at an appropriate time.

To be more specific, the parties need to firstly identify possible stakeholders that may raise inquiries/concerns to SAMR and anticipate theiꦍr possible concerns of such identified stakeholders. Based on such, the parties shall further come up with an outreach plan on when to approach stakeholders, the attendees of the expected meeting, how to explain the transaction background and relevant information, and how to address their concerns and the correspondi💮ng solutions in order to alleviate their concerns to the greatest extend.

For the identified stakeholders, such reachout may happen more than once and as the reviewing process moving forward, the reachout strategy and the topics may need to be tailor-made and adjusted from time to time. If the parties’ proposed solution can in fact alleviate stakeholders’ concerns, the expectation is that there won't be a lot of complaints by market participants escalating to the regulator's level, which in turn may facilitate the review process and benefit the review outcome (ideally by receiving a clearance without conditions).

Remedy Design, Implementation and Lifting

Remedy design and negotiation

As mentioned above, when SAMR concludes that the proposed transaction will likely impede competition, instead of suggesting appropriate remedies, SAMR will hold the alignment meeting to communicate its competition concerns to the parties (similar to the EU Commission’s statement of objection (SO)) and the parties must then formulate appropriate and corresponding remedies proposals that would effectively alleviate SAMR’s concerns. Upon receipt, SAMR will evaluate the effectiveness, feasibility and timeliness of the commit🌄ment proposal and will notify the parties the evaluation outcome.[4] Through several rounds of remedy negotiations and market test(s), SAMR may eventually deem whether the commitment proposal is sufficient to eliminate the identified concerns. If yes, SAMR will clear the transaction with conditions; if the notifying parties fail to address SAMR’s competition concerns, the transaction may be blocked or the parties may decide to proactively abandon the deal.

ܫHence, the appropriate design of commitment proposals sometimes means “the life or death” of a deal and the below three key considerations deserve special attention when doing so.

Tailor the commitment proposal to SAMR’s competition concerns

In line with global trends, SAMR accepts commitments in two categories, structural remedies (such as divestiture of tangible assets and intangible assets like intellectual property, data, etc.) and behavioural remedies (such as no price increase, continuous stable supply on FRAND terms, no tied-up sales, no reduction in the level of in🐼teroperability, hold separate, etc.). With various types of remedy at hand, it is paramount to identify and select the appropriate remedy approach to address and eliminate SAMR’s identified concerns, which is the overarching principle when designing the commitments. Such design is a dedicated work requiring an in-depth understanding of the theory of harm, close and effective communications with SAMR and the flexible use of various remedies alone or in combination.

Take the latest case as an example, in Broadcom/VMware (2023),[5] SAMR raised concerns mostly in regard to the merged entities’ conglomeraterelations, and in addressing those concerns, behaviour remedy would be more to the point than structural remedy and SAMR eventually accepted tailor-made behaviour commitments, among others, not to engage in tie-in sales, to ensure interoperability, and to take protective measures for possible unjustified use of rivals’ confidential information, etc. It is worth mentioning that the Broadcom/VMwaredeal were notified in various jurisdictions, including the EU, the US, Korea, China, etc. This case also appears to be a showcase where peer competition regulators would cooperate in the merger review process. Comparing the review decisions from different jurisdictions, it is observed that the competition concerns being addressed are basically the same, while the imposed remedies are divergent to certain extent. For example, both EU Decision and China Decision accepted the parties’ commitments to ensure interoperability with VMware's server virtualisation software, but the scope of the remedies accepted by SAMR appears to be broader, and the level of granularity appears to be higher. 

Take account of both efficiency and feasibility when designing the commitment proposal

The ideal approach for designing a commitment proposal efficiently is to ensure the proposal is just﷽ sufficient enough to address SAMR’s competition concerns while avoiding imposing disproportionate burdens on the daily operation of the obligor(s). The parties need to weigh the pros and cons of different types of remedies and carefully consider the concrete content of the proposal and the viab🐲ility for the implementation before submitting it to SAMR.

From the efficiency perspective, generally speaking, structural remedies would eliminate SAMR’s competition concerns once and for all and would affect the parties immediately, directly and in a relatively shorter period (typically within one year),[6] whereas behaviour remedies require the obligor(s), i.e., the undertaking to perform the relevant obligations, to devote constant efforts to the implementation in a longer period (usually longer than five years judging from the most recent SAMR cases). Despite this, one cannot confidently conclude that the parties should prioritise structural remedies over behaviour remedies because the🐷 obligor(s) is required to work with immense workloads and intense timelines in the year when primary obligations of structural remedies are implemented, while the w🎀orkload of behaviour remedies are typically averagely scattered during the whole implementation period.

From the feasibility perspective, it is important and essential to make sure the proposal is both feasible and workable and would not result in an adverse impact on the routine business of the obligor(s). This requires a close and in-depth teamwork - typically, the legal department, along with outside counsels, would put forward a proposal draft, and such draft is advisable to be reviewed and adjusted by other related business units, such as the sales and R&D departments, so that the commitmentౠ proposal could fit into the business model and corporate governance of the obligor(s), and after all would benefit and ease the actual implementation 🐼of the commitments.

Align and coordinate commitment proposals globally

High-profile cross-border transactions usually need to obtain green lights in several jurisdictions. During the reviewing process, competition authorities from different jurisdictions normally would exchange views and information on the transactions, especially when discussing and evaluating the proposed remedies. For example, since 2015, Directorate-General (DG) for Competition, the European Competition Authority, and MOFCOM have signed best practices for cooperation on reviewing mergers, facilitating information sharing be꧅tween the two competition authorities and allowing them to discuss timetables at key stages of investigations with each other and with the merging companies.[7] China has also signed memorandums of understanding to enhance cooperation in competition law enforcement with several other countries, such as the US,[8] Korea and Japan.[9] Sometimes, when a global divestiture is expected to be adopted, peer regulators would need to evaluate the consistency of their subset to the global divestiture. Thus, it is important for the parties (together with outside counsels from different jurisdictions) to fully align and coordinate commitment proposals globally so that the implementation of commitments worldwide would not result in possible conflicts, which might eventually lead to compliance issues.

Remedy implementation

Implementing structural remedies in a cost-effective way

Under the regime of Chinese merger regulations, the implementation of structural remedies, in particular divestitures, shall follow a strict timeline. Normally, it could be considered appropriate to retain a period of approximately six months for finding a suitable buyer and concluding the sale and purchase agreement (an extension of an extra three months can be realized subject to SAMR’s approval), and an additional period of three months for transferring the divestment business.[10] Given such a strict timelin🔯e, it is pivotal to come up with a well-planned transaction roadmap and key milestones that adhere to SAMR’s requirement, and then follow it strictly and diligently, avoiding any deviations from the timeline. To this end, the below three aspects stand at the heart of the whole process, during which creating the needed conditions for the emergence of a viable and competitive competitor against the merged entity serves as the general baseline.

■  Delineating the scope of the Divested Business. The Divested Business refers to the business which the notifying party(ies) commit to divest to resolve the regulator🤡’s competition concerns once for all. The scope of the Divested Business shall be no smaller than a viable business that, if operated by a suitable purchaser, can compete effectively with the merged entity on a sustainable basis.

■  Providing all potential buyers with equal opportunities to obtain sꦐufficient information of the Divested Business. This is explicitly stipulated as a mandatory obligation for the obligor(s) before the completion of the divestiture,[11] aiming at preserving the viability, competitiveness, and marketability of the Divested Business.

■  Findi🍸ng a suitable purchaser. This process is with the greatest importance and aims to ensure that the Divested Business will be sold to a suitable purchaser who is independent of and unconnected to the notifying party(ies) and their affiliated undertakings, and who possesses the financial resources, proven expertise and incentive to maintain and develop the Divested Business as a viable and active competitive for💛ce in the marketplace. In evaluating a suitable purchaser, SAMR would look at the issue from both incentive and capability perspectives.

Implementing behaviour remedies in a cost-effective way

Behaviour remedies provide for the rules that the obligor(s) should follow and comply with during its daily operation within the implementation period. The obligor(s) will be required to submit compliance report to SAMR and the monitoring trustee in writing on a regular basis (usually once a year or every six months). Hence, implementing the remedies in a cost-effective way is crucial to both satisfy the compliance requirements as set fort꧑h in SAMR’s review decision and maintain the routine business un-disturbed nor negatively impacted.

Based on our experience, it is recommended for obligor(s) to adopt a top-down approach to realize such balance: the obligor(s) to set up effect𒐪ive compliance mechanisms at the early stage of implementation and to execute them accordingly. For example, to address the competition concerns in relation to the unjustified use of rivals’ data for the advantage of the obligor(s), SAMR usually accepts ring-fencing obligations, ranging from signing confidentiality agreements, storing confidential information separately and preventing the use of the same, to ensuring the separation of relevant personnel etc. In adopting the top-down approach in this scenario, it is recommended for the obligor(s) to formulate protocols and set up firewall procedures, as early as deemed appropriate, which could serve as guiding principles/rules for the obligor(s) to follow and execute, lessening uncertainties and benefiting the implementation afterwards.

Iꦚn addition, it is also recommended, in an innovative way, to make full use of the already-established tools of the obligor(s), which have already been used for its internal management. Taking supply commitment as an example, to prove that the obligor(s) has fulfilled required deliveries in a full volume and in time, the obligor(s), instead of using traditional methods by colle𒅌cting a large number of paper evidence, is recommended to make full use of the existing data on its existing business management system, which is supposed to contain the full set of data of the complete process of “order to cash”, sparing the workloads in relation to the time-consuming manual information gathering exercise. Likewise, obligor(s) can also dig deep into other available tools and use those established tools innovatively for the sake of efficiency and effectiveness to satisfy compliance requirements.

Remedy lifting or modifying
SAMR’s review decision will stipulate the time period for the imposed restrictive conditions, which can be either automatically lifted upon expiration (on the condition that there has been no violation of the review decision) or via the obligor(s)’ application.[12]
The imposed restrictive conditions can also be modified or lifted during the effective period of the review decision, proactively by SAMR or upon the obligor(s)’ application and SAMR’s consent. While evaluating whether or not to modify or lift the conditions, SAMR will consider the following factors:[13]
●  Whether a party to the concentration has undergone material changes;
●  Whether the competition of the relevant market has undergone substantial changes;
●  Whether it is unnecessary or impossible to impose the restrictive conditions;
●  Other factors that shall be considered.

Similar to the review process, SAMR will also carry out market test(s) and solicit third-party stakeholders’ opinions toꩵwards the proposed modification or lifting of the conditions. If the market test(s) result is positive and no concerns/objections are raised, SAMR will conclude the final conclusion and publicize the decision accordingly. However, if the market test(s) result is negative, further negotiations with SAMR would be needed in order to respond to and address stakeholders’ concerns, and sometimes the obligor(s) may need to take a step back and adjust its application.

Referenced in this article

●  China’s Anti-Monopoly Law
(//www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art﷽_f0fae9eb3a684fc39e84d89eabfc2caa.html)

●  Provisions on the Review of Concentrations of Undertakings (🌼//www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art_4c34a8aa4e62449ab38233bdbba172a7.html)
●  Rules of the State Council on the Declaration Standards for Concentration of Undertakings (//www.samr.gov.cn/fldes/j🧸yzjzsbxbz/art/2024/art_eb4235b9a196486c8df15c7a61d51744.html)
●  The cooperation framework/memorandum for antitrust/merger review between China and other jurisdictions (the US, the EU, and Japan etc.) (EU press release: Commission signs best practices cooperation framework with China, available at: //ec.europa.eu/commission/presscorner/detail/en/IP_15_5843. U.S. - China Memorandum🔜 of Understanding on Antitrust and Antimonopoly Cooperation, available at: //www.ftc.gov/legal-library/browse/cooperation-agreements/us-china-memorandum-understanding-antitrust-antimonopoly-cooperation-english-chinese-version. Press rele𝐆ase from SAMR, available at: //www.samr.gov.cn/xw/zj/art/2023/art_bc1eb3b3f9f348fdafeb313d653f8f35.html)
●  MaxLinear/Silicon Motion (2023) (//www.♔samr.gov.cn/fldys/tzgg/ftj/art/2023/art_b46495b0b7b0408ca0e1da7707🌳1679af.html)
●  Broadcom/VMware (2023)(//www.samr.gov.cn:8890/fldes/tzgg/☂ftj/art/2023/art_cae805a5e37d489ea929af8a4a369f6b.html%E3%80%82)
●  SAMR – The State Administration for Market Regulation in China(//www.samr.gov.cn/)
● MOFCOM – the Anti-monopoly Bureau of the Ministry of Commerce, the predecessor ♋of SAMR(//fldj.mofcom.gov.c⛄n/)

往上走滚动阅览引用

[1]🗹 See: //mp.weixin.qq.com/s/zztXx4nxiMRBhMiC9Ezqhw.

[2] The deal was cleared unconditionally in US, but MaxLinear announced that it has exercised its contractual rights to terminate the 💧merger agreement with Silicon Motion (the same day of 🍨SAMR’s issuance of its review decision).

[3] Article 1 of the AML stipulates that ‘the present Law is enacted for the purpose of preventing and restraining monopolistic practices, protecting fair market competition, encouraging innovation, improving economic efficiency, safeguarding the interests of consumers and the public, and promoting the sound development of the socialis🃏t market economy.’

[4] See Articles 39 of the Provisions on the Reᩚᩚᩚᩚᩚᩚ⁤⁤⁤⁤ᩚ⁤⁤⁤⁤ᩚജ⁤⁤⁤⁤ᩚ𒀱ᩚᩚᩚview of Concentrations of Undertakings.

[5] Broad🦋com/VMware (2023), availabl𝐆e at: //www.samr.gov.cn/fldes/tzgg/ftj/art/2023/art_cae805a5e37d489ea929af8a4a369f6b.html.

[6] See Articles 48 & 49 of the Provisions🌺 on the Review of Concentrations of Undertakings.

[7]🅠 See EU press release: Commission signs best practices cooperation framework with China, available at://ec.europa💮.eu/commission/presscorner/detail/en/IP_15_5843.

[8] See U.S. - China Memorandum of Understanding on Antitrust and Antimonopoly Coopera꧂tion, available at: //www.ftc.gov/legal-library/browse/cooperation-agreements/us-china-memorandum-understanding-antitrust-antimonopoly-cooperation-english-chinese-version.

[9] See press relea🌺se from SAMR, available at: //www.samr.gov.cn/xw/zj/art/2023/art_bc1eb3b3f9f348fdafeb313d653f8f35.html.

[10] See Articles 48 & 49 of th𝐆e Provisions on the Review of Concentrations of Under𝐆takings.

[11] Se♛e Article 51 of 💃theProvisions on the Review of Concentrations of Undertakings.

[12🐬] See Article 54 of the Provisions on the Review ༺of Concentrations of Undertakings.

[13] S⛎ee Article 55 of the Provisions on the Review of Concentrations of Undertakings.





Haiwen Antitrust Group was invited to author an article for the Global Competition Review - "Asia-Pacific Antitrust Review 2024"

引言



近几日,海问反垄断市场行业工作组受國际信赖民事法律互联网媒体《全世界之间的竞争平论》(Global Competition Review)的特邀,为其“华东反垄断市场行业平论2024”栏目组下“Insight”板块龙头股发文,应用场景在𒊎我国在操作者聚集查看区域新型的卫生监督执法实行,说了僵化转让申报纳税系统软件的加工处理并所以供应了有用的实施细则与体会。

Recently, the authoritative international legal media Global Competition Review invited Haiwen Antitrust Group to author an Insight article for its Asia-Pacific Antitrust Review 2024. The article provides practical guidance and insights for handling merger control procedures of complex deals based on China’s most recent enfor🔜cement practice.

反垄断-1.jpg
Navigating Merger Review of Complex Deals under Chinese Anti-Monopoly Law in an Ever-Changing World
In summary
China’s Anti-Monopoly Law and the accompanying regulations concerning merger control have undergone significant changes in the past years. Amid the legislative changes and the ever-changing geopolitical conditions, the Chinese competition authority continues to hold a decisive influence on progressing complex cross-border deals with global impact. This article aims to provide practical guidance and insights for handling merger control procedures of complex deals based on China’s most recent enforcement practice. It highlights topics from planning optimal merger filing strategies to key considerations in remedy design and implementation.

Discussion points

· Identification of a complex deal

· Meger filing strategies for a complex deal

· Remedy design and negotiation when competition coꦅncerns are identified

· Implementation of remedies in a cost-effeಌctওive way

· Remedy lifting and modification


Introduction

The year 2023 witnesses the 15th anniversary of the enactment of China’s Anti-Monopoly Law (“AML”) and the first anniversary of its amendment. The State Administration for Market Regulation (“SAMR”), the Chinese competition regulatory authority, released the Provisions on the Review of Concentrations of Undertakings to adapt the accompanying regulations to the amended AML. At the beginning of 2024, SAMR revised the Rules of the State Council on the Declaration Standards for Concentration of Undertakings, which increased the turnover threshol🍷ds for merger control notifications⛦.

Amid the above legislative improvements, China maintains its crucial presence in the global economy, contﷺinuing to attract international market players and giving rise to the fact that an enormous number of international M&A deals are required to put forward ex ante notifications before SAMR. The statistics published by SAMR show that 797 cases were accepted by SAMR in 2023 alone, 782 of which were approved unconditionally and 4 of which were approved with remedies. Deals involving foreign enterprises account for 44% of the cases approved.[1]

Most notably, SAMR’s decision plays a decisive role in progressing forward many high-profile deals with global influence in 2023, for instance, the MaxLinear/Silicon Motion (2023)[2] and Broadcom/VMware (2023). Although the turnover thresholds for merger notifications were elevated, which may lead to a decrease of approximately 200 cases annually, high-profile deals that are likely to restrict or eliminate competition or relate to certain industries with some special strategic considerations will still be under the spotlight of ✨SAMR’s review. We term those deals as “complex deals” and will discuss in this article on how to navigate the merger review of them properly under the context of amended AML.

The article aims at providing practical guidance for handling complex deals over the lifetime of its review process under the AML, based on SAMR’s recent practice. We first reveal the characteristics of complex deals and advise on the way of planning and designing appropriate and feasible merger filing stra🎀tegies thereof. We then explore and highlight the key considerations in remedy design and implementation when the deal comes to the stage where relevant parties are required to propose and implement remedies.

The identification of a complex deal and the merger control filing strategy thereof

With the changing trade climate and the attendant upsurge in complicated geopolitics, it seems that the recent M&A deals tend to grind to a halt. Despite that, as one of the world’s important nexus for manufacturing and market activities, China is still a fertile ground for international deals of a high-profile nature.

Since the enactment of the AML in 2008, cases cleared with remedies by SAMR or its predecessor, the Anti-monopoly Bureau of the Ministry of Commerce (“MOFCOM”), have been a unique spotlight across worldwide major antitrust jurisdictions - as the world's largest manufacturing country, it is natural to look at issues from different perspectives, so that there will be differences in market definition, competitive analysis, etc. For those high-profile international deals, identifying the complexity of the deal appropriately and navigating the merger control filing strategy in advance have naturally become pivotal to progressing the deal.

The identification of a complex deal

In order to address the regulator’s concerns to facilitate the merg🍰er review process, one has to appropriately identify whether the deal in question constitutes a “complex” one. Normally, there are two perspectives that are of consideration in this regard: competition asse𓄧ssment and industrial policy evaluation.

Competition assessment

Competition assessment is at the heart of a merger control review. Transactions that have or may have any effect of eliminating or restricting competition in China will certainly complicate the review process and lengthen the timelines. The regulator would take an in-depth review of the notifying parties’ submission of an assessme🌜nt of the concentration’s competitive impact, evaluate any potential competition concerns and seek any possible commitments or remedies that can ease the concerns.

In order for the parties to identify a complex deal from a competition assessment perspective and be prepared in advance, one needs to learn what factors would be under SAMR’s radar. In line with international antitrust regulator’s practice, SAMR would adopt the theories of harm and assess the unilateral or coordinated🌱 effects for horizontal mergers and evaluate the foreclosure effects in case of vertical or conglomerate mergers. The following factors would be primarily considered in SAMR’s review process:

■ ജ Market share, including the partie🐬s’ market position;

■  The degree of market concentration, which can be reflected via the Herfindahl-Hirschman Index (HHI) or the combined market shares of the top N enterprises 🥃in 🎀the relevant market (CRn index);

■  The impact of 🌺the concentration on market entry and⛦ technological advancement;

■  The impact of the concentrat𒅌ion on consumers and other third parties (suppliers, competitors, counterparties, etc.);

■  The competition landscape an🐻d the market competitiveness pre and post the concentration; and

■  The impact of the c💖oncentration on economic efficiency, business scale and scope, and cos𓆉t reduction.

It is worth mentioning that compared with other jurisdictions, SAMR tends to take a closer examination of those cases with high market shares despite the deal is a conglomerate transaction. Based on observations on SAMR’s recent practice, its conglomerate concerns primarily shadow on the possible tying, imposing less favourable trade terms post-transaction, refusal to deal, degradi🅘ng interoperability, etc.

Industrial policy evaluation

In addition to weighing the competition-wide effects, other factors closely related to economic development, such as industrial policy, are also taken into account in the review process, which is in line with the legislative purpose of the AML set out in Article 1 thereof (safeguarding the interests of consumers and the public and promoting the sound development of the socialist market economy).[3] To be more specific, SAMR would consider the impact of the concentration on national economic development, i.e., SAMR would analyse the impact on economic efficiency, business scale, the development of the relevant industries, etc. In other words, SAMR would analyse industrial policy concerns during merger review process, in particular in deaཧls involving industrie✨s that are of strategic importance to China and/or closely related to people’s livelihood, such as electronic information, semiconductor, aerospace, ocean engineering, new energy, new materials, agriculture, pharmaceuticals, etc. Thus, deals which fall within the above industries might need to be paid rigorous attention.

Taking deals in the field of agriculture as an example, despite moderate market shares in the relevant markets, if the deals are likely to have a significant and strat𒉰egic impact on the agricultural value chain and thereby on people’s livelihood, they would be, in most cases, subject to strict and lengthy scrutiny and may be approved with restrictive conditions.

Given such, while a complex deal is at hand or around🔜 the corner, a close and early planned monitoring of the concerned ꦏindustrial policies issued by the relevant governmental authority or trade association is a pragmatic and advisable approach.

The merger control filing strategy for a complex deal

As SAMR is increasingly playing an active role in reviewing complex deals, understanding China’s regulatory dynamics and practice, proactively planning and designing appropriate and feasible merger control filing strategy thereof, and adjusting such str🍷ategy from time to time based on actual reviewing process will help the deals gain an edge in getting clearance. While strategy-planning and designing may need to consider various perspectives, the following factors, among others, shall be weighed substantially.

Conduct holistic analysis towards the relevant markets and the competition landscape

Whereas a deal has been identified as a complex one, the traditional competition perspective assessment (as illustrated above) shall have already been properly conducted by the parties. However, a more holistic and in-depth analysis towards the relevant markets and the competition landscape might contribute more to addressing and alleviating SAMR’s potential concerns. Most of SAMR’s competition concerns stem from possible synergies the transaction parties might have and any input/customer foreclosure the transaction may result in. Thus, beyond the corresponding stances under the traditional competition perspective, it is advisable t🧸o take a closer assessment of the rate of capacity utilization, countervailing power from buyers, dynamic impact of new technology on the relevant industry, as well as any efficiency increment. Engaging economists and conducting detailed economic analysis might be of assistance as well.

Maintain an adequate and constructive communication with SAMR

For complex deals, adequate and constructive communications with SAMR tend to play a crucial part in smoothing the reviewing process. The communications can be of two parts: pre-filing and post-filing.

The parties can choose to take advantage of SAMR’s pre-filing consultation mechanism and apply for a preliminary communication with SAMR, during which the parties can seek SAMR’s guidance on procedural (such as review length, filing requirements, etc.) or substantive issues (such as market definition, market data calculatio♋n, industry policy, etc.) under the scheduled notification. The parties can then be more prepared and adjust/supplement the filing materials accordingly. Through this, SAMR’s inquiries on the completeness of the filing materials may be reduced to a certain extent and therefore might shorten SAMR’s pre-acceptance period.

Procedurally, upon SAMR’s formal acceptance of the case, SAMR will seek third-party stakeholders’ opinions on the transaction, which is a formal process under the non-simplified filing procedure. Usually, stakeholders 🀅would include PRC customers, suppliers, trade associations, sector regulators, etc., and their views and concerns would play an essential role when SAMR formulates its attitudes and competit🦩ion concerns over the case. Thus, it is advisable to keep a smooth communication with SAMR post-acceptance, especially to anticipate proactive communications after SAMR receives stakeholders’ opinions to get a sense on whether received opinions are negative/positive/neutral.

If SAMR preliminarily identifies competitive concerns oveꦛr the case and intends to require remedies, it will normally call for a meeting to convey such concerns to the parties. The parties would then be required to formulate a commitment proposal to SAMR to address those concerns and to explain why such commitments could be able to lift those concerns effectively, which will lead to rounds of back-and-forth negotiations and discussions between parties and SAMR on possible remedies. For cases also being filed in other jurisdictions, SAMR would commonly exchange review opinions with its peer regulators, thus, parties need to coordinate remedy proposals across different juri✤sdictions as well, and maintain continuous and effective communications with both SAMR and its peer regulators.

Initiate appropriate and pragmatic stakeholders reachouts

As being mentioned above, stakeholders’ views and concerns over the transaction could be pivotal to SAMR’s stance on the necessity to impose remedies. In order to take initiatives over the reviewing process (including possible remedy negotiation process) and formulate a𝄹 commitment proposal (if needed) as soon as possible that can eff♉ectively address SAMR’s concerns and pass SAMR’s market test(s), the parties need to take the stakeholders reachouts seriously and commence the process at an appropriate time.

To be more specific, the parties need to firstly identify possible stakeholders that may raise inquiries/concerns to SAMR and anticipate their possible concerns of such identified stakeholders. Based on such, the parties shall further come up with an outreac♓h plan on when to approach stakeholders, the attendees of the expected meeting, how to explain the transaction background and relevant information, and how to address their concerns and the corresponding solutions in order to alleviate their concerns to the greatest extend.

For the identified stakeholders, such reachout may happen more than once and as the reviewing process moving forward, the reachout strategy and the topics may need to be tailor-made and adjusted from time to time. If the parties’ proposed solution can in fact alleviate stakeholders’ concerns, the expectation is that there won't be a lot of complaints by market participants escalating to the regulator's level, which in turn may facilitate the review process and benefit the review outcome (ideally by receiving a clearance without conditions).

Remedy Design, Implementation and Lifting

Remedy design and negotiation

As mentioned above, when SAMR concludes that the proposed transaction will likely impede competition, instead of suggesting appropriate remedies, SAMR will hold the alignment meeting to communicate its competition concerns to the parties (similar to the EU Commission’s statement of objection (SO)) and the parties must then formulate appropriate and corresponding remedies proposals that would effectively alleviate SAMR’s concerns. Upon receipt, SAMR will evaluate the effectiveness, feasibility and timeliness of the commitment proposal and will notify the parties the evaluation outcome.[4]&nb🥀sp;Through several rounds of remedy negotiations and market test(s), SAMR may eventually deem whether the commitment proposal is sufficient to eliminate the identified concerns. If yes, SAMR will clear the transaction with conditions; if the notifying parties fail to address SAMR’s competition concerns, the transaction may be blocked or the parties may decide to proactively abandon the deal.

Hence, the appropriate design of commitment proposals some♒times means “the life or death” of a deal and the below three key considerations deserve special a𝔉ttention when doing so.

Tailor the commitment proposal to SAMR’s competition concerns

In line with global trends, SAMR accepts commitments in two categories, structural remedies (such as divestiture of tangible assets and intangible assets like intellectual property, data, etc.) and behavioural remedies (such as no price increase, continuous stable supply on FRAND terms, no tied-up sales, no ♔reduction in the level of interoperability, hold separate, etc.). With various types of remedy at hand, it is paramount to identify and select the appropriate remedy approach to address and eliminate SAMR’s identified concerns, which is the overarching principle when designing the commitments. Such design is a dedicated work requiring an in-depth understanding of the theory of harm, close and effective communications with SAMR and the flexible use of va𒀰rious remedies alone or in combination.

Take the latest case as an example, in Broadcom/VMware (2023),[5] SAMR raised concerns mostly in regard to the merged entities’ conglomeraterelations, and in addressing those concerns, behaviour remedy would be more to the point than structural remedy and SAMR eventually accepted tailor-made behaviour commitments, among others, not to engage in tie-in sales, to ensure interoperability, and to take protective measures for possible unjustified use of rivals’ confidential information, etc. It is worth mentioning that the Broadcom/VMwaredeal were notified in various jurisdictions, including the EU, the US, Korea, China, etc. This case also appears to be a showcase where peer competition regulators would cooperate in the merger review process. Comparing the review decisions from different jurisdictions, it is observed that the competition concerns being addressed are basically the same, while the imposed remedies are divergent to certain extent. For example, both EU Decision and China Decision accepted the parties’ commitments to ensure interoperability with VMware's server virtualisation software, but the scope of the remedies accepted by SAMR appears to be broader, and the level of granularity appears to be higher. 

Take account of both efficiency and feasibility when designing the commitment proposal

The ideal approach for designing a commitment proposal 💧efficiently is to ensure the proposal is just sufficient enough to address SAMR’s competition concerns while avoiding imposing disproportionate burdens on the daily operation of the obligor(s). The parties need to weigh the pros and cons of different types of remedies and carefully consider the concrete content of the proposal and the viabilit🔯y for the implementation before submitting it to SAMR.

From the efficiency perspective, generally speaking, structural remedies would eliminate SAMR’s competition concerns once and for all and would affect the parties immediately, directly and in a relatively shorter period (typically within one year),[6] whereas behaviour remedies require the obligor(s), i.e., the undertaking to perform the relevant obligations, to devote constant efforts to the implementation in a longer period (usually longer than five years j🐠udging from the most recent SAMR cases). Despite this, one cannot confidently conclude that the parties should prioritise structural remedies over behaviour remedies because the obligor(s) is required to work with immense workloads and intense timelines in the year when primary obligations of structural remedies are implemented, while the workload of behaviour remedies are typically averagely scattered during the whole implementation period.

From the feasibility perspective, it is important and essential to make sure the proposal is both feasible and workable and would not result in an adverse impact on the routine business of the obligor(s). This requires a close and in-depth teamwork - typically, the legal department, along with outside counsels, would put forward a proposal draft, and such draft is advisable to be reviewed and adjusted by other related business units, such as the sales and R&D departments, so that the commitment proposal coꦑuld fit into the business model and corporate governance of the obligor(s), and after all would benefit and ease the actual implಌementation of the commitments.

Align and coordinate commitment proposals globally

High-profile cross-border transactions usually need to obtain green lights in several jurisdictions. During the reviewing process, competition authorities from different jurisdictions normally would exchange views and information on the transactions, especially when discussing and evaluating the proposed remedies. For example, since 2015, Directorate-General (DG) for Competition, the European Competition Authority, and MOFCOM have signed best practices for cooperation on reviewing mergers, facilitating information sharing between the two competition authorities and allowing them to discuss timetables at key stages of investigations with each other and with the merging companies.[7] China has also signed memorandums of understanding to enhance cooperation in competition law enforcement with several other countries, such as the US,[8] Korea and Japan.[9] Sometimes, when a global divestiture is expected to be adopted, peer regulators would need to eval🙈uate the consistency of their subset to the global divestiture. Thus, it is important for the parties (together with outside counsels from different jurisdictions) to fully align and coordinate commitment proposals globally so that the implementation of commitments worldwide would not result in possible conflicts, which might eventually lead to compliance issues.

Remedy implementation

Implementing structural remedies in a cost-effective way

Under the regime of Chinese merger regulations, the implementation of structural remedies, in particular divestitures, shall follow a strict timeline. Normally, it could be considered appropriate to retain a period of approximately six months for finding a suitable buyer and concluding the sale and purchase agreement (an extension of an extra three months can be realized subject to SAMR’s approval), and an additional period of three months for transferring the divestment business.[10] Given such a strict timeline, it is pivotal to come up with a well-planned transaction roadmap and key milestones that adhere to SAMR’s requirement, and then follow it strictly and diligently, avoiding any deviations from the timeline. To this end, the below three aspects stand at the heart of the whole process, during which creating the needed conditions for the emergenಞce of a viable and competitive competitor against the merged entity serves as the general baseline.

■  Delineating the scope o𒈔f the Divested Business. The Divested Business refers to the business which the notifying party(ies) commit to divest to resolve the regulator’s competitio༒n concerns once for all. The scope of the Divested Business shall be no smaller than a viable business that, if operated by a suitable purchaser, can compete effectively with the merged entity on a sustainable basis.

■  Providing all potential buyers with equal opportunities to obtain sufficient information of the Divested Business. This is explicitly stipulated as a mandatory obligation for the obligor(s) before the completion of the divestiture,[11] aiming at preserving the viability, competitiveness, and marketability of the Divꦅested Business.

■  Finding a suitable purchaser. This process is with the greatest importance and aims to ensure that the Divested Business will be sold to a suitable purchaser who is independent of and unconnected to the notifying party(ies) and their affiliated undertakings, and who possesses the financial resources, proven expertise and incentive to maintain and develop the Divested Business as a viable and active competitive force in the marketplace. In evaluating a suitable purchaser, SAMR would look at the issue from both incentive and capaꦚbility perspectives.

Implementing behaviour remedies in a cost-effective way

Behaviour remedies provide for the rules that the obligor(s) should follow and comply with during its daily operation within the implementation period. The obligor(s) will be required to submit compliance report to SAMR and the monitoring trustee in writing on a regular basis (usually onc𒁃e a year or every six months). Hence, implementing the remedies in a cost-effective way is crucial to both satisfy the compliance requirements as set forth in SAMR’s review decision and maintain the routine business un-disturbed nor negatively impacted.

Based on our experience, it is recommended for obligor(s) to adopt a top-down approach to realize such balance: the obligor(s) to set up effective compliance mechanisms at the early stage of implementation and to execute them accordingly. For example, to address the competition concerns in relation to the unjustified use of rivals’ data for the advantage of the obligor(s), SAMR usually accepts ring-fencing obligations, ranging from signing confidentiality agreements, storing confidential information separately and ♌preventing the use of the same, to ensuring the separation of relevant personnel etc. In adopting the top-down approach in this scenario, it i😼s recommended for the obligor(s) to formulate protocols and set up firewall procedures, as early as deemed appropriate, which could serve as guiding principles/rules for the obligor(s) to follow and execute, lessening uncertainties and benefiting the implementation afterwards.

In addition, it is also recommended, in an innovative way, to make full use of the already-established tools of the obligor(s), which have already been used for its internal management. Taking supply commitment as an example, to prove that the obligor(s) has fulfilled required deliveries in a full volume and in time, the obligor(s), instead of using traditional methods by collecting a large number of paper evidence, is recommended to make full use of the existing data on its existing business management system, which is supposed to contain the full set of data of the complete process of “order to cash”, sparing the workloads in relation to the time-consuming manual information gathering e🧸xercise. Likewise, obligor(s) can also dig deep into other available tools and use those established tools innovatively for the sake of efficiency and effectiveness to satisfy compliance requirements.

Remedy lifting or modifying
SAMR’s review decision will stipulate the time period for the imposed restrictive conditions, which can be either automatically lifted upon expiration (on the condition that there has been no violation of the review decision) or via the obligor(s)’ application.[12]
The imposed restrictive conditions can also be modified or lifted during the effective period of the review decision, proactively by SAMR or upon the obligor(s)’ application and SAMR’s consent. While evaluating whether or not to modify or lift the conditions, SAMR will consider the following factors:[13]
●  Whether a party to the concentration has undergone material changes;
●  Whether the competition of the relevant market has undergone substantial changes;
●  Whether it is unnecessary or impossible to impose the restrictive conditions;
●  Other factors that shall be considered.

Similar to the review process, SAMR will also carry out market test(s) and solicit third-party stakeholders’ opinions towards the proposed modification or lifting of the conditions. If the market test(s) result is positive and no concerns/objections are raised, SAMR will conclude the final conclusion and publicize the decision accordingly. However, if the market test(s) result is negative, f💝urther negotiations with SAMR would be needed in order to respond to and address stakeholders’ concerns, and sometimes the obligor(s) may need to take a step back and adjust its 🌼application.

Referenced in this article

●  China’s Anti-Monopoly Law
(//www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art_f0fae9eb3a684fc39e84d8ꦐ9eabfc2caa.html)

●  Provisions on the Review of Concentrations of Undertakings (//www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art_4c34a8aa4e62♊449ab38233bdb🐲ba172a7.html)
●  Rules of the State Council on the Declaration Standards for Concentration of Undertakings (//www.samr.gov.cn/fldes/jyzjzsbxbz/art/2024/art_eb4235b9a1964ꦜ86c8df15c7a61d51744.html)
●  The cooperation framework/memorandum for antitrust/merger review between China and other jurisdictions (the US, the EU, and Japan etc.) (EU press release: Commission signs best practices cooperation framework with China, available at: //ec.europa.eu/commission/pressꦿcorner/detail/en/IP_15_5843. U.S. - China Memorandum of Understanding on Antitrust and Antimonopoly Cooperation, available at: //www.ftc.gov/legal-library/browse/cooperation-agreements/us-china-memorandum-understanding-antitrust-antimonopoly-cooperation-english-chinese-version. Press release from SAMR, available at: //www.samr.gov.cn/xw/zj/art/2023/art_bc1eb3b3f9f348fdafeb313d653f8f35.html)
●  MaxLinear/Silicon Motion (2023) (//www.samr.gov.cn/fldys/tzgg/ftj/art/2023/art_b46495b0b7b0408ca0e1da77071679🃏af.html)
●  Broadcom/VMware (2023)(//www.samr.gov.cn:8890/fldes🌞/tzgg/ftj/art/2023/art_cae805a5e37d489ea929af8a4a369f6b.htm🌞l%E3%80%82)
●  SAMR – The State Administration for Market Regulation in China(//www.samr.gov.cn/)
● MOFCOM – the Anti-monopoly Buꩵreau of the Ministry of Commerc💝e, the predecessor of SAMR(//fldj.mofcom.gov.cn/)

朝上滚动条阅览参考文献标注

[1] See: //mp.weixin.qq.com/s/zzt🍸Xx4nxiMRBhMiC9Ezqhw.

[2] The deal was cleared unconditionally in US, but MaxLinear announced that it has exercised its contract♛ual rights to terminate the merger agreement with Silicon Motion (the same day of SAMR’ꦗs issuance of its review decision).

[3] Article 1 of the AML stipulates that ‘the p𝕴resent Law is enacted for the purpose of preventing and restraining monopolistic practices, protecting fair market competition, encouraging innovation, improving economic efficiency, safegജuarding the interests of consumers and the public, and promoting the sound development of the socialist market economy.’

[4] See Articles 39 of the Provisions on the Review of Concentrations of Unde🧜rtakings.

[5] Broadcom/VMware (2023), available at: //www.samr.gov.cn/fldes/tzgg/🅘ftj/art/2023/art_cae805a5e37d489ea929af8a4a369f6b.html.

[6] See Articles 48 & 49 of the Provisions on the Review of Concentra🍰tions of Undertakings.

[7] See EU 𒈔press release: Commission signs best practices cooperation framework with China, available at://ec.europa.euဣ/commission/presscorner/detail/en/IP_15_5843.

[8] See U.S. - China Memorandum of Underꦉstanding on Antitrust and Antimonopoly Cooperation, available at: //www.ftc.gov/legal-library/browse/cooperation-agreements/us-china-memorandum-understanding-antitrust-antimonopoly-cooperation-english-chinese-version.

[9] See press release from SAMR, availabl🙈e at: //www.samr.gov.cn/xw/zj/art/2023/art_bc1eb3b3f9f348fdafeb313d653f8f35.html.

[10] See Articles 48 & 49 of the Provisions on the Review oꦅf Concentrations of Undertakings.

[11] See Ar🌼ticle 51 of thePro🏅visions on the Review of Concentrations of Undertakings.

[12🍸] See Article 54 of the Provisions on the Review of Concentrations of U🐈ndertakings.

[13] See Art🏅icle 55 of the Provisions on the Review of Concentrations of Undertakings.





Contact Us
Address:20/F Fortune Financial Center 5 Dong San Huan Central Road Chaoyang District Beijing 100020, China
Telephone:+86 10 8560 6888
Fax:+86 10 8560 6999
Mail:haiwenbj@tfulatex.com
Address:Unit 2605,Jing An Kerry Center Tower 1 No.1515 Nan Jing West Road Jing'an District Shanghai 200040, China
Telephone:+86 21 6043 5000
Fax:+86 21 5298 5030
Mail:haiwensh@tfulatex.com
Address:Suites 1101-1104, 11/F, One Exchange Square, 8 Connaught Place, Central, Hong Kong, China
Telephone:+852 3952 2222
Fax:+852 3952 2211
Mail:haiwenhk@tfulatex.com
Address:Room 3801, Tower Three, Kerry Plaza 1 Zhong Xin Si Road, Futian District, Shenzhen 518048, China
Telephone:+86 755 8323 6000
Fax:+86 755 8323 0187
Mail:haiwensz@tfulatex.com
Address:Unit 01, 10-12, 20/F, China Overseas International Center Block C, 233 Jiao Zi Avenue, High-tech District, Chengdu 610041, China
Telephone:+86 28 6391 8500
Fax:+86 28 6391 8397
Mail:haiwencd@tfulatex.com
Address:Room 3508-3509, 35/F, Hainan Building 5 Guoxing Avenue, Meilan District Haikou 570100, China
Telephone:+86 898 6536 9667
Fax:+86 898 6536 9667
Mail:haiwenhn@tfulatex.com
Beijing ICP No. 05019364-1 Beijing Public Network Security 110105011258
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7fDzSfyJvbjbD",ck:"K9y7fDzSfyJvbjbD"}); 鸿博体育(中国)官方网站 · app下载 芒果体育·(中国)官方网站 - MANGGUO SPORTS 芒果体育·(中国)官方网站-IOS/安卓/手机版APP下载 芒果体育(中国)官方网站 芒果体育(中国)官方APP下载-IOS/安卓通用版/手机APP下载